DE69329994T2 - Arylalkoxyphenoxyimidazolinverbindungen - Google Patents

Arylalkoxyphenoxyimidazolinverbindungen

Info

Publication number
DE69329994T2
DE69329994T2 DE69329994T DE69329994T DE69329994T2 DE 69329994 T2 DE69329994 T2 DE 69329994T2 DE 69329994 T DE69329994 T DE 69329994T DE 69329994 T DE69329994 T DE 69329994T DE 69329994 T2 DE69329994 T2 DE 69329994T2
Authority
DE
Germany
Prior art keywords
compounds
arylalcoxyphenoxyimidazoline
arylalkoxyphenoxy
anxiety
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329994T
Other languages
English (en)
Other versions
DE69329994D1 (en
Inventor
Jules Freedman
M Baron
W Dudley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/832,556 external-priority patent/US5216008A/en
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69329994D1 publication Critical patent/DE69329994D1/de
Application granted granted Critical
Publication of DE69329994T2 publication Critical patent/DE69329994T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Reinforced Plastic Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69329994T 1992-02-06 1993-01-12 Arylalkoxyphenoxyimidazolinverbindungen Expired - Fee Related DE69329994T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/832,556 US5216008A (en) 1992-02-06 1992-02-06 Arylalkoxyphenoxy-imidazoline compounds
US99017492A 1992-12-24 1992-12-24
PCT/US1993/000238 WO1993016051A1 (en) 1992-02-06 1993-01-12 Arylalkoxyphenoxy-imidazoline compounds

Publications (2)

Publication Number Publication Date
DE69329994D1 DE69329994D1 (en) 2001-04-12
DE69329994T2 true DE69329994T2 (de) 2001-06-28

Family

ID=27125545

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329994T Expired - Fee Related DE69329994T2 (de) 1992-02-06 1993-01-12 Arylalkoxyphenoxyimidazolinverbindungen

Country Status (19)

Country Link
US (1) US5407954A (de)
EP (1) EP0625969B1 (de)
JP (1) JPH07504167A (de)
KR (1) KR100276994B1 (de)
AT (1) ATE199547T1 (de)
CA (1) CA2129142A1 (de)
DE (1) DE69329994T2 (de)
DK (1) DK0625969T3 (de)
ES (1) ES2156868T3 (de)
FI (1) FI943637A (de)
GR (1) GR3035915T3 (de)
HU (1) HUT67527A (de)
IL (2) IL104600A0 (de)
MX (1) MX9300601A (de)
NO (1) NO304597B1 (de)
NZ (1) NZ246823A (de)
PT (1) PT625969E (de)
TW (1) TW366338B (de)
WO (1) WO1993016051A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0408470A1 (de) * 1989-07-06 1991-01-16 Eastman Kodak Company Maleinisiertes Polypropylen-Gemisch und Verwendung zu Schmelzklebern
CA3025884C (en) * 2016-06-24 2023-03-07 Ohio University Glucose transport inhibitors and methods of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695555A1 (de) * 1967-02-23 1970-07-16 Nordmark Werke Gmbh Neue Aryloxy-isoalkyl-delta2-imidazoline und deren Saeureadditionssalze sowie Verfahren zu ihrer Herstellung
CA2027530C (en) * 1989-10-20 2001-05-08 Jules Freedman W-phenoxy-heterocyclic compounds

Also Published As

Publication number Publication date
NZ246823A (en) 1996-06-25
DE69329994D1 (en) 2001-04-12
DK0625969T3 (da) 2001-04-30
ES2156868T3 (es) 2001-08-01
FI943637A0 (fi) 1994-08-05
NO304597B1 (no) 1999-01-18
EP0625969A1 (de) 1994-11-30
TW366338B (en) 1999-08-11
HUT67527A (en) 1995-04-28
MX9300601A (es) 1993-08-01
HU9402283D0 (en) 1994-10-28
NO942917L (no) 1994-08-05
ATE199547T1 (de) 2001-03-15
FI943637A (fi) 1994-08-05
KR100276994B1 (ko) 2002-06-20
PT625969E (pt) 2001-08-30
KR950700260A (ko) 1995-01-16
IL122537A0 (en) 1998-06-15
GR3035915T3 (en) 2001-08-31
JPH07504167A (ja) 1995-05-11
AU3442293A (en) 1993-09-03
WO1993016051A1 (en) 1993-08-19
AU671270B2 (en) 1996-08-22
NO942917D0 (de) 1994-08-05
EP0625969B1 (de) 2001-03-07
US5407954A (en) 1995-04-18
IL104600A0 (en) 1993-06-10
CA2129142A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
SE9502893D0 (sv) Användning av kollagenas
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
DK0406211T3 (da) Fucosidase-inhibitorer
DE69230224D1 (de) Potenzierung von nmda-antagonisten
NO984245D0 (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
DK0625969T3 (da) Arylalkoxyphenoxyimidazolinforbindelser
FI953002A (fi) Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla
DK1019347T3 (da) Fremgangsmåde til syntesen af taxaner
ATE267209T1 (de) Reinigung von carboxaldehyd
ATE144899T1 (de) Derivate des 1-piperidinyl- alkanoylarylsulfonamids
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
UA40497A (uk) Спосіб лікування генералізованого катарального гінгівіту
MX9706424A (es) Uso de la moxonidina para el tratamiento de la aterosclerosis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee